{"id":3681,"date":"2017-08-12T19:17:47","date_gmt":"2017-08-12T19:17:47","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/non-invasive-treatment\/"},"modified":"2026-02-09T09:04:58","modified_gmt":"2026-02-09T09:04:58","slug":"hypertermi-ikke-invasiv-kreftbehandling","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/","title":{"rendered":"Ikke-invasiv behandling, synergisk med kjemoterapi, radio- og immunterapi"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/onkologisk-rf-hypertermienhet\/#hydeep-600wm\",\n      \"name\": \"Andromedic HyDeep 600WM\",\n      \"image\": [\n        \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/03\/Andromedic-HY-DEEP-600-WM-884x1024-1.jpg\",\n        \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/03\/PC-HIPerformance-Andromedic-HyDeep600WM-1024x1024.jpg\"\n      ],\n      \"description\": \"HyDeep 600 WM er et avansert system\/enhet for onkologisk hypertermi, system\/enhet for dyp lokal hypertermi, system\/enhet for modulert RF-hypertermi og system\/enhet for elektro-hypertermi. Profesjonelt medisinsk utstyr for selektiv destruksjon av kreftceller ved bruk av modulert 13,56 MHz radiofrekvens.\",\n      \"brand\": { \n        \"@type\": \"Brand\",\n        \"@id\": \"https:\/\/andromedichyperthermia.com\/#brand\",\n        \"name\": \"Andromedic\"\n      },\n      \"manufacturer\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" },\n      \"sku\": \"HYDEEP-600WM-NO-NI\",\n      \"aggregateRating\": {\n        \"@type\": \"AggregateRating\",\n        \"ratingValue\": \"4.9\",\n        \"reviewCount\": \"40\",\n        \"bestRating\": \"5\",\n        \"worstRating\": \"4\"\n      },\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/no\/onkologisk-rf-hypertermienhet\/\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"price\": \"0.00\",\n        \"priceCurrency\": \"EUR\",\n        \"description\": \"Pris p\u00e5 foresp\u00f8rsel\"\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. Veronica Iatan\" },\n        \"reviewBody\": \"De spesifikke protokollene i HyDeep 600WM-systemet representerer et fremragende fremskritt for kliniske resultater innen hypertermi.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/\",\n      \"name\": \"13,56 MHz modulert RF-hypertermi (mHT) \u2013 En ikke-invasiv kreftbehandling\",\n      \"description\": \"Omfattende guide om modulert RF-hypertermi (mHT) som en ikke-invasiv medisinsk intervensjon ved bruk av HyDeep 600WM-enheten.\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"inLanguage\": \"nb-NO\",\n      \"lastReviewed\": \"2026-02-09\",\n      \"reviewedBy\": { \n        \"@type\": \"Person\",\n        \"name\": \"Dr. Veronica Iatan\"\n      },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/#therapy\" },\n      \"about\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/onkologisk-rf-hypertermienhet\/#hydeep-600wm\" }\n    },\n    {\n      \"@type\": \"MedicalTherapy\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/#therapy\",\n      \"name\": \"Modulert RF-hypertermi (mHT)\",\n      \"description\": \"En ikke-invasiv kreftterapi levert via HyDeep 600WM-enheten, som kombinerer termiske og elektromagnetiske effekter.\",\n      \"relevantSpecialty\": { \"@type\": \"MedicalSpecialty\", \"name\": \"Oncology\" },\n      \"device\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/onkologisk-rf-hypertermienhet\/#hydeep-600wm\" }\n    },\n    {\n      \"@type\": \"BreadcrumbList\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/#breadcrumb\",\n      \"itemListElement\": [\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 1,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/\", \"name\": \"Hjem\" }\n        },\n        {\n          \"@type\": \"ListItem\",\n          \"position\": 2,\n          \"item\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/no\/hypertermi-ikke-invasiv-kreftbehandling\/\", \"name\": \"Ikke-invasiv behandling\" }\n        }\n      ]\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Hyperthermia\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/no\/\",\n      \"logo\": {\n        \"@type\": \"ImageObject\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/logo.png\"\n      }\n    }\n  ]\n}\n<\/script><\/p>\n<div class=\"andromedic-content-section\" style=\"font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;\">\n<div style=\"text-align: center; padding: 50px 20px; background: linear-gradient(180deg, #f0f7ff 0%, #ffffff 100%); border-radius: 0 0 30px 30px; margin-bottom: 40px;\">\n<h1 style=\"color: #004a99; font-size: 2.3em; line-height: 1.2; margin-bottom: 20px;\">Ikke-invasiv kreftbehandling:<br \/>\n<span style=\"color: #003366; font-weight: 400;\">13,56 MHz modulert RF-hypertermi (mHT)<\/span><\/h1>\n<p style=\"font-size: 1.15em; line-height: 1.8; color: #444; max-width: 950px; margin: 0 auto;\">Radiofrekvent (RF) hypertermi er en innovativ og <strong>fullstendig ikke-invasiv<\/strong> onkologisk intervensjon. Ved bruk av 13,56 MHz elektromagnetiske b\u00f8lger for selektiv m\u00e5lretting av maligne celler, sensibiliseres tumorer for standardterapier uten fysiske traumer. <span style=\"color: #004a99; font-weight: 600;\">Den ikke-invasive naturen er en klinisk fordel<\/span>: ingen kirurgiske snitt, n\u00e5ler eller punkteringer er n\u00f8dvendig.<\/p>\n<\/div>\n<div style=\"display: flex; flex-wrap: wrap; gap: 40px; align-items: flex-start; margin-bottom: 60px; padding: 0 20px;\">\n<div style=\"flex: 1.2; min-width: 350px;\">\n<figure style=\"margin: 0; box-shadow: 0 15px 35px rgba(0,0,0,0.1); border-radius: 15px; overflow: hidden;\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"576\" class=\"wp-image-517\" style=\"width: 100%; display: block;\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1.webp\" alt=\"HyDeep 600WM Modulert RF-hypertermi-enhet - Ikke-invasiv kreftbehandling\" title=\"\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1.webp 1024w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1-300x169.webp 300w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Video-HYDEEP-HQ-SalvatoreSettaggi_Moment-1024x576-1-768x432.webp 768w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><figcaption style=\"padding: 20px; background: #f9f9f9; font-size: 0.95em; color: #555; border-top: 1px solid #eee; line-height: 1.6;\"><strong>Andromedic HyDeep 600WM<\/strong>, et avansert system for onkologisk hypertermi, illustrerer perfekt den ikke-invasive naturen til mHT, og gir maksimal patientkomfort uten bruk av kirurgiske instrumenter.<\/figcaption><\/figure>\n<p style=\"margin-top: 25px; font-size: 1.1em; line-height: 1.7; color: #333; padding-left: 20px; border-left: 4px solid #004a99;\">Fagfellevurderte kliniske studier viser at integrering av mHT i onkologiske protokoller forbedrer <strong>total overlevelse (OS)<\/strong>, lokal tumorkontroll (LTC) og pasientens livskvalitet. <a style=\"color: #004a99; text-decoration: none; font-weight: bold;\" title=\"Se vitenskapelig referanse for modulert elektro-hypertermi\" href=\"https:\/\/www.mdpi.com\/2072-6694\/15\/18\/4569\" target=\"_blank\" rel=\"noopener\">(Vitenskapelig referanse)<\/a><\/p>\n<\/div>\n<div style=\"flex: 0.8; min-width: 300px; background: #f4f7fa; padding: 30px; border-radius: 20px;\">\n<nav aria-label=\"Hurtignavigasjon\">\n<h4 style=\"margin-top: 0; color: #003366; border-bottom: 2px solid #004a99; padding-bottom: 10px; text-transform: uppercase; font-size: 0.9em; letter-spacing: 1px;\">Vitenskapelig navigasjon:<\/h4>\n<ul style=\"list-style: none; padding: 0; margin: 20px 0 0 0;\">\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section1\">Virkningsmekanisme<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section2\">Synergi med cellegift<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section3\">Aktivering av immunterapi<\/a><\/li>\n<li style=\"margin-bottom: 12px;\"><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section4\">Palliativ og adjuvant bruk<\/a><\/li>\n<li><a style=\"text-decoration: none; color: #004a99; font-weight: 500;\" href=\"#section5\">Kliniske resultater<\/a><\/li>\n<\/ul>\n<\/nav>\n<\/div>\n<\/div>\n<section id=\"section1\" style=\"margin-bottom: 60px; padding: 40px; background: #fff; border: 1px solid #e1e8f0; border-radius: 20px; text-align: center;\">\n<h2 style=\"color: #004a99; margin-bottom: 20px;\">Biofysiske mekanismer og kliniske fordeler med modulert RF<\/h2>\n<p style=\"max-width: 850px; margin: 0 auto; font-size: 1.1em; line-height: 1.8; color: #555;\">Mekanismen bak <strong>modulert RF-hypertermi<\/strong> er mangefasettert; den p\u00e5virker tumormikromilj\u00f8et (TME) og den systemiske immunresponsen, samtidig som den opprettholder en strengt ikke-invasiv profil.<\/p>\n<\/section>\n<h2 id=\"section2\" style=\"color: #004a99; text-align: center; margin-bottom: 40px;\">Klinisk synergi: Forsterkning av standard onkologiske terapier<\/h2>\n<div style=\"display: flex; flex-wrap: wrap; gap: 30px; margin-bottom: 50px; padding: 0 20px;\">\n<div style=\"flex: 1; min-width: 320px; background: #fff; border: 1px solid #e1e8f0; padding: 35px; border-radius: 20px; box-shadow: 0 5px 15px rgba(0,0,0,0.03);\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.4em;\">1. Synergi med kjemoterapi (perfusjon)<\/h3>\n<p style=\"line-height: 1.7; color: #444;\">mHT utl\u00f8ser lokalisert vasodilatasjon i tumormikrosirkulasjonen, noe som fasiliterer overlegen intratumoral perfusjon av cytotoksiske midler.<\/p>\n<div style=\"background: #f0f7ff; padding: 15px; border-radius: 10px; border-left: 4px solid #004a99; margin-top: 15px;\"><strong>Terapeutisk effekt:<\/strong> Potenserer effekten av kjemoterapi <strong>uten \u00e5 \u00f8ke systemisk toksisitet<\/strong>.<\/div>\n<\/div>\n<div style=\"flex: 1; min-width: 320px; background: #fff; border: 1px solid #e1e8f0; padding: 35px; border-radius: 20px; box-shadow: 0 5px 15px rgba(0,0,0,0.03);\">\n<h3 style=\"color: #cc0000; margin-top: 0; font-size: 1.4em;\">2. Radiosensibilisering (reoksygenering)<\/h3>\n<p style=\"line-height: 1.7; color: #444;\">Ved \u00e5 forbedre intratumoral oksygenering, eliminerer mHT radioresistente hypoksiske fraksjoner, noe som gj\u00f8r tumorcellene betydelig mer mottakelige for str\u00e5lebehandling.<\/p>\n<div style=\"background: #fff5f5; padding: 15px; border-radius: 10px; border-left: 4px solid #cc0000; margin-top: 15px;\"><strong>Radiosensibiliserende effekt:<\/strong> Forsterker str\u00e5leresponsen via en <strong>pasientvennlig, ikke-aggressiv protokoll<\/strong>.<\/div>\n<\/div>\n<\/div>\n<section id=\"section3\" style=\"margin-bottom: 60px; padding: 45px; background: #f8fbff; border-radius: 25px; border: 1px solid #d0e1f5;\">\n<div style=\"text-align: center; margin-bottom: 40px;\">\n<div style=\"display: inline-block; background: #004a99; color: #fff; padding: 5px 15px; border-radius: 50px; font-size: 0.85em; font-weight: bold; margin-bottom: 15px; text-transform: uppercase; letter-spacing: 1px;\">Avansert immunonkologi<\/div>\n<h2 style=\"color: #003366; margin-top: 0;\">Aktivering av immunsystemet via modulert RF<\/h2>\n<p style=\"max-width: 800px; margin: 0 auto; font-size: 1.1em; line-height: 1.7; color: #444;\">Modulert RF-hypertermi fungerer som en katalysator for anti-tumor immunrespons gjennom biologiske signalveier.<\/p>\n<\/div>\n<div style=\"display: flex; flex-direction: column; gap: 25px;\">\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 30px; border-radius: 15px; box-shadow: 0 4px 12px rgba(0,0,0,0.03);\">\n<h4 style=\"color: #004a99; margin: 0 0 10px 0; font-size: 1.25em;\">Immunogen celled\u00f8d (ICD) og DAMPs<\/h4>\n<p style=\"line-height: 1.7; color: #333;\">mHT induserer <strong>ICD<\/strong>, noe som utl\u00f8ser frigj\u00f8ring av <em>Damage-Associated Molecular Patterns (DAMPs)<\/em>. Disse signalene varsler immunsystemet og fremmer langsiktig immunologisk minne gjennom en ikke-invasiv stimulans.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 30px; border-radius: 15px; box-shadow: 0 4px 12px rgba(0,0,0,0.03);\">\n<h4 style=\"color: #004a99; margin: 0 0 10px 0; font-size: 1.25em;\">Systemisk effekt: Abscopal-effekten<\/h4>\n<p style=\"line-height: 1.7; color: #333;\">Lokal mHT-behandling kan indusere systemisk anti-tumorrespons i fjerne metastaser, og fungerer som en ikke-invasiv partner til kontrollpunkthemmere.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"section4\" style=\"margin-bottom: 60px; padding: 0 20px;\">\n<h2 style=\"color: #004a99; text-align: center; margin-bottom: 40px;\">Kliniske anvendelser: Et sk\u00e5nsomt alternativ for alle stadier<\/h2>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 25px;\">\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">Adjuvant og neoadjuvant st\u00f8tte<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">\u00d8ker suksessraten for prim\u00e6rbehandlinger <strong>uten \u00e5 legge til invasiv belastning<\/strong> i den kliniske protokollen.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">Palliativ pleie og smertebehandling<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">Reduserer kreftrelaterte smerter betydelig. Den sk\u00e5nsomme metoden forbedrer livskvaliteten (QoL) i avanserte stadier av onkologi.<\/p>\n<\/div>\n<div style=\"background: #ffffff; border: 1px solid #e1e8f0; padding: 25px; border-radius: 15px; border-top: 4px solid #004a99;\">\n<h3 style=\"color: #004a99; margin-top: 0; font-size: 1.2em;\">Inflammatoriske patologier<\/h3>\n<p style=\"font-size: 0.95em; line-height: 1.6; color: #444;\">Behandler kronisk inflammasjon og samtidige patologier gjennom den samme <strong>trygge, ikke-invasive teknologien<\/strong>.<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section id=\"section5\" style=\"background: linear-gradient(135deg, #004a99 0%, #002b5c 100%); color: #ffffff; padding: 50px; border-radius: 30px; position: relative; overflow: hidden; margin-bottom: 50px;\">\n<div style=\"position: relative; z-index: 2; text-align: center;\">\n<h2 style=\"color: #ffffff; margin-top: 0; margin-bottom: 25px;\">Klinisk evidens og fremtidsperspektiver<\/h2>\n<div style=\"display: flex; flex-wrap: wrap; gap: 30px; justify-content: center; margin-bottom: 40px;\">\n<div style=\"background: rgba(255,255,255,0.1); padding: 20px 40px; border-radius: 15px; border: 1px solid rgba(255,255,255,0.2);\"><span style=\"display: block; font-size: 2em; font-weight: bold;\">\u00d8kt<\/span><a style=\"color: #fff; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/no\/hypertermi-overlevelse-kreftpasienter\/\"><span style=\"font-size: 1.1em; opacity: 0.9;\">total overlevelse (OS)<\/span><\/a><\/div>\n<div style=\"background: rgba(255,255,255,0.1); padding: 20px 40px; border-radius: 15px; border: 1px solid rgba(255,255,255,0.2);\"><span style=\"display: block; font-size: 2em; font-weight: bold;\">&#x2728; Forbedret<\/span><a style=\"color: #fff; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/no\/hypertermi-livskvalitet-qol\/\"><span style=\"font-size: 1.1em; opacity: 0.9;\">livskvalitet (QoL)<\/span><\/a><\/div>\n<\/div>\n<p style=\"font-size: 1.15em; line-height: 1.8; max-width: 850px; margin: 0 auto;\">Modulert RF-hypertermi (mHT) er en essensiell evidensbasert terapi som maksimerer effekt gjennom en <strong>ikke-invasiv metode<\/strong> som respekterer pasientens velv\u00e6re.<\/p>\n<\/div>\n<div style=\"position: absolute; right: -50px; bottom: -50px; font-size: 15em; opacity: 0.05; color: #fff; font-weight: 900;\">mHT<\/div>\n<\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Modulert RF-hypertermi (mHT) er en ikke-invasiv intervensjon som utnytter elektromagnetiske b\u00f8lger for \u00e5 selektivt m\u00e5lrette maligne vev, samtidig som friske celler bevares.<br \/>\nSom en kraftfull multimodal synergist, forsterker mHT effekten av kjemoradioterapi, immunterapi og kontrollpunkthemmere (checkpoint inhibitors).<\/p>\n<p>Ved bruk av HyDeep 600WM (et avansert system for lokal dyp hypertermi) oppn\u00e5r terapien betydelig radiosensibilisering (reoksygenering) og overlegen perfusjon av kjemoterapeutika.<br \/>\nUtover den termiske effekten, modulerer systemet tumormikromilj\u00f8et (TME) og utl\u00f8ser immunogen celled\u00f8d (ICD) samt frigj\u00f8ring av DAMPs.<br \/>\nDisse mekanismene sikrer forbedret total overlevelse (OS), lokal tumorkontroll og \u00f8kt livskvalitet. <\/p>\n<p>Dette er en ideell adjuvant eller palliativ l\u00f8sning for onkologiske patologier, kronisk inflammasjon og smertebehandling.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-3681","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages\/3681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/comments?post=3681"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/pages\/3681\/revisions"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/no\/wp-json\/wp\/v2\/media?parent=3681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}